dc.contributor.author | Neher, Jon O. | eng |
dc.contributor.author | Safranek, Sarah | eng |
dc.date.issued | 2003 | eng |
dc.description.abstract | Three beta-blockers--carvedilol, metoprolol, and bisoprolol--reduce mortality in chronic heart failure caused by left ventricular systolic dysfunction, when used in addition to diuretics and angiotensin converting enzyme (ACE) inhibitors (strength of recommendation [SOR]: A, based on large randomized placebo-controlled trials). No differences in mortality or patient tolerance have been demonstrated in studies comparing carvedilol and metoprolol (SOR: B, based on small head-to-head trials). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/2976 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2003 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 52, no. 05 (May 2003): 396+. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | patient tolerance | eng |
dc.subject | mortality | eng |
dc.subject | angiotensin converting enzyme (ACE) inhibitors | eng |
dc.subject | systolic dysfunction | eng |
dc.subject.lcsh | Angiotensin converting enzyme -- Inhibitors -- Therapeutic use | eng |
dc.subject.lcsh | Congestive heart failure -- Treatment | eng |
dc.subject.lcsh | Adrenergic beta blockers | eng |
dc.title | What is the most effective beta-blocker for heart failure? | eng |
dc.type | Article | eng |